Marie Zhu
Chief Technology Officer WuXi XDC
Seminars
Wednesday 10th June 2026
Advancing Dual-Payload ADC (dp-ADC) Development with Proprietary WuXiDARx™, X-LinC, & WuXiTecan-2
5:15 pm
- Advancing next-generation dual-payload ADCs to address traditional challenges like drug resistance and narrow therapeutic windows
- Leveraging WuXiDARx™ technology for flexible DAR1-6 and WuXiTecan2™ hydrophilic linker, enabling streamlined dual-payload construction without antibody engineering
- Demonstrating a substantially wider therapeutic index alongside significantly enhanced anti-tumor efficacy in proof-of-concept studies
